Cargando…
Serum 25-Hydroxyvitamin D Is Differentially Associated with Early and Late Age-Related Macular Degeneration in the United States Population
Background: Age-related macular degeneration (AMD) has been the leading cause of irreversible blindness in industrialized countries. Emerging data suggest that serum vitamin D levels may be associated with AMD but show mixed results. National-level population data on the relationship between vitamin...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005371/ https://www.ncbi.nlm.nih.gov/pubmed/36904215 http://dx.doi.org/10.3390/nu15051216 |
_version_ | 1784905063680966656 |
---|---|
author | Fu, Yihang Chen, Xiaoyun Luo, Sheng Jiang, Shuangyan Mao, Yuxiang Xiao, Wei |
author_facet | Fu, Yihang Chen, Xiaoyun Luo, Sheng Jiang, Shuangyan Mao, Yuxiang Xiao, Wei |
author_sort | Fu, Yihang |
collection | PubMed |
description | Background: Age-related macular degeneration (AMD) has been the leading cause of irreversible blindness in industrialized countries. Emerging data suggest that serum vitamin D levels may be associated with AMD but show mixed results. National-level population data on the relationship between vitamin D and AMD severities are still lacking. Methods: We used data from the National Health and Nutrition Examination Survey (NHANES) 2005 to 2008. Retinal photographs were taken and graded for AMD stage. The odds ratio (OR) of AMD and its subtype was calculated after adjusting for confounding factors. Restricted cubic spline (RCS) analyses were used to explore potential non-linear relations. Results: A total of 5041 participants with a mean age of 59.6 years were included. After adjusting for covariates, participants with higher level of serum 25-hydroxyvitamin D [25(OH)D] had significantly greater odds of early AMD (OR, 1.65; 95% CI, 1.08–2.51) and decreased risk of late AMD (OR, 0.29; 95% CI, 0.09–0.88). When stratified by age, a positive association between the level of serum 25(OH)D and early AMD was present in the <60 years group (OR, 2.79; 95% CI, 1.08–7.29), whereas a negative relation between the level of serum 25(OH)D and late AMD was detected in the ≥60 years group (OR, 0.24; 95% CI, 0.08–0.76). Conclusions: A higher level of serum 25(OH)D was related to increased risk of early AMD in those <60 years and decreased risk of late AMD in those ≥60 years. |
format | Online Article Text |
id | pubmed-10005371 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100053712023-03-11 Serum 25-Hydroxyvitamin D Is Differentially Associated with Early and Late Age-Related Macular Degeneration in the United States Population Fu, Yihang Chen, Xiaoyun Luo, Sheng Jiang, Shuangyan Mao, Yuxiang Xiao, Wei Nutrients Article Background: Age-related macular degeneration (AMD) has been the leading cause of irreversible blindness in industrialized countries. Emerging data suggest that serum vitamin D levels may be associated with AMD but show mixed results. National-level population data on the relationship between vitamin D and AMD severities are still lacking. Methods: We used data from the National Health and Nutrition Examination Survey (NHANES) 2005 to 2008. Retinal photographs were taken and graded for AMD stage. The odds ratio (OR) of AMD and its subtype was calculated after adjusting for confounding factors. Restricted cubic spline (RCS) analyses were used to explore potential non-linear relations. Results: A total of 5041 participants with a mean age of 59.6 years were included. After adjusting for covariates, participants with higher level of serum 25-hydroxyvitamin D [25(OH)D] had significantly greater odds of early AMD (OR, 1.65; 95% CI, 1.08–2.51) and decreased risk of late AMD (OR, 0.29; 95% CI, 0.09–0.88). When stratified by age, a positive association between the level of serum 25(OH)D and early AMD was present in the <60 years group (OR, 2.79; 95% CI, 1.08–7.29), whereas a negative relation between the level of serum 25(OH)D and late AMD was detected in the ≥60 years group (OR, 0.24; 95% CI, 0.08–0.76). Conclusions: A higher level of serum 25(OH)D was related to increased risk of early AMD in those <60 years and decreased risk of late AMD in those ≥60 years. MDPI 2023-02-28 /pmc/articles/PMC10005371/ /pubmed/36904215 http://dx.doi.org/10.3390/nu15051216 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Fu, Yihang Chen, Xiaoyun Luo, Sheng Jiang, Shuangyan Mao, Yuxiang Xiao, Wei Serum 25-Hydroxyvitamin D Is Differentially Associated with Early and Late Age-Related Macular Degeneration in the United States Population |
title | Serum 25-Hydroxyvitamin D Is Differentially Associated with Early and Late Age-Related Macular Degeneration in the United States Population |
title_full | Serum 25-Hydroxyvitamin D Is Differentially Associated with Early and Late Age-Related Macular Degeneration in the United States Population |
title_fullStr | Serum 25-Hydroxyvitamin D Is Differentially Associated with Early and Late Age-Related Macular Degeneration in the United States Population |
title_full_unstemmed | Serum 25-Hydroxyvitamin D Is Differentially Associated with Early and Late Age-Related Macular Degeneration in the United States Population |
title_short | Serum 25-Hydroxyvitamin D Is Differentially Associated with Early and Late Age-Related Macular Degeneration in the United States Population |
title_sort | serum 25-hydroxyvitamin d is differentially associated with early and late age-related macular degeneration in the united states population |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005371/ https://www.ncbi.nlm.nih.gov/pubmed/36904215 http://dx.doi.org/10.3390/nu15051216 |
work_keys_str_mv | AT fuyihang serum25hydroxyvitamindisdifferentiallyassociatedwithearlyandlateagerelatedmaculardegenerationintheunitedstatespopulation AT chenxiaoyun serum25hydroxyvitamindisdifferentiallyassociatedwithearlyandlateagerelatedmaculardegenerationintheunitedstatespopulation AT luosheng serum25hydroxyvitamindisdifferentiallyassociatedwithearlyandlateagerelatedmaculardegenerationintheunitedstatespopulation AT jiangshuangyan serum25hydroxyvitamindisdifferentiallyassociatedwithearlyandlateagerelatedmaculardegenerationintheunitedstatespopulation AT maoyuxiang serum25hydroxyvitamindisdifferentiallyassociatedwithearlyandlateagerelatedmaculardegenerationintheunitedstatespopulation AT xiaowei serum25hydroxyvitamindisdifferentiallyassociatedwithearlyandlateagerelatedmaculardegenerationintheunitedstatespopulation |